FemOne

FemmePharma Global Healthcare is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for women's health conditions, particularly those related to menopause and sexual health. The company specializes in creating non-hormonal and low-dose hormonal therapies that address vulvovaginal atrophy (VVA) and female sexual dysfunction through targeted delivery systems. Their portfolio includes both over-the-counter (OTC) products under the Satisfem and Luvena brands, as well as a clinical-stage pipeline of prescription therapeutics. FemmePharma aims to provide safer alternatives to traditional systemic hormone replacement therapies by focusing on localized treatment options. Founded by industry veteran Gerianne DiPiano, the company operates with a mission to improve the quality of life for women by addressing underserved medical needs in gynecology.